Peter Grydholdt Sørensen
Direttore/Membro del Consiglio presso Ejendomsselskabet Hvidovre Torv AS
Provenienza dei contatti di primo grado di Peter Grydholdt Sørensen
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Ejendomsselskabet Hvidovre Torv AS
Ejendomsselskabet Hvidovre Torv AS Real Estate DevelopmentFinance Part of Ejendomsselskabet Hvidovre Torv Holding AS, Ejendomsselskabet Hvidovre Torv AS engages in rental of commercial real estate properties. The company is based in Aarhus, Denmark.
4
| Subsidiary | Real Estate Development | 4 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Peter Grydholdt Sørensen tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
Novo Holdings AS (Denmark)
Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Financial Conglomerates | Corporate Officer/Principal | |
Livingston International, Inc.
Livingston International, Inc. Air Freight/CouriersTransportation Livingston International, Inc. engages in provision of customs brokerage, transportation and integrated logistics services. Its services include customs brokerage, U.S. customs brokerage, Canadian customs brokerage, Mexican customs brokerage, freight and transportation, global trade management, trade consulting, trade technology, business process services, trade sphere and vehicle transportation services. The company was founded by Gerry Livingston in 1945 and is headquartered in Toronto, Canada. | Air Freight/Couriers | Director/Board Member | |
Technical University of Denmark | College/University | Graduate Degree | |
EpiTherapeutics ApS
EpiTherapeutics ApS BiotechnologyHealth Technology EpiTherapeutics ApS is a holding company that develops cancer drugs based on research in the field of epigenetics. Its development programs are focused on enzymes involved in the regulation of transcription in cancer - current programs target histone demethylases and methyltransferases. The firm's regulation is commonly used for post-translational covalent modifications of histones and other chromatin-remodeling complexes, which determines whether a gene is accessible and hence, expressed or repressed. Its covalent modifications involved in epigenetic regulation include deoxyribonucleic acid methylation, histone acetylation, and histone methylation. The company was founded by Kristian Helin, Paul Andreas Compare Cloos, Jesper Aagaard Christensen, Karl Agger, and Klaus Hansen on September 18, 2008 and is headquartered in Greve, Denmark. | Biotechnology | Director/Board Member | |
Dansk Biotek
Dansk Biotek Miscellaneous Commercial ServicesCommercial Services Dansk Biotek is an industry association for biotech companies with promoting the biotechnological research, development and production in taking care of corporate interests in this regard, both nationally and internationally. The company was founded in 1987 and is headquartered in Copenhagen, Denmark. | Miscellaneous Commercial Services | Director/Board Member | |
Novo Seeds
Novo Seeds Investment ManagersFinance Novo Seeds (Novo Seeds) is a venture capital operating division of Novo Nordisk Fonden. The firm was established in 2007, and is headquartered in Hellerup, Denmark. | Investment Managers | Director of Investments | |
Danske Spil A/S
Danske Spil A/S Media ConglomeratesConsumer Services Danske Spil A/S provides lotteries and gambling services. The company was founded on July 21, 1948 and is headquartered in Brondby, Denmark. | Media Conglomerates | Director/Board Member | |
Reapplix A/S
Reapplix A/S Medical DistributorsDistribution Services Reapplix A/S specializes in the biological treatment and management of diabetic foot ulcers. It develops the LeucoPatch device, which is composed of precision molded medical grade plastic components, that facilitates a processing of autologous blood. The company was founded by Niels Erik Holm and Rasmus Lundquist in 2008 and is headquartered in Birkerod, Denmark. | Medical Distributors | Director/Board Member | |
Galecto Biotech ApS
Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Galecto Biotech ApS provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Its products include galectin-3 inhibitors, fibrosis and literature. The company was founded by Tariq Sethi, Hans Thalsgard Schambye, Ulf Jorgen Nilsson, and Hakon Leffler in 2011 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Director/Board Member | |
Forendo Pharma Oy
Forendo Pharma Oy Pharmaceuticals: MajorHealth Technology Forendo Pharma Oy provides novel pharmaceutical treatments for endometriosis and low testosterone levels. Its product fispemifene is the first selective estrogen receptor modulator designed only for men, which helps for the treatment of symptoms of low testosterone, in phase II clinical studies in men with secondary hypogonadism; fispemifene has normalized the low testosterone levels. Its 17HSD1-inhibitor focuses on endometriosis, is a potent and selective lead compounds demonstrated in vivo proof of efficacy in disease model of endometriosis. The company was founded by Risto Arvo Sakari Lammintausta in 2013 and is headquartered in Turku, Finland. | Pharmaceuticals: Major | Director/Board Member | |
Biosyntia ApS
Biosyntia ApS BiotechnologyHealth Technology Biosyntia ApS provides services in synthetic biology and metabolic engineering fields. It offers biocatalysts for fermentation of fine chemicals. The company was founded by Andreas Hougaard Laustsen, Morten Otto Alexander Sommer, and Hans Jasper Genee in 2012 and is headquartered in Copenhagen, Denmark. | Biotechnology | Director/Board Member | |
NorthSea Therapeutics BV
NorthSea Therapeutics BV BiotechnologyHealth Technology NorthSea Therapeutics BV operates as a biotechnology company. It develops oral, structurally engineered fatty acid therapeutics. The company was founded by Hilde H. Steineger and David A. Fraser and is headquartered in Naarden, the Netherlands. | Biotechnology | Director/Board Member | |
GALECTO, INC. | Pharmaceuticals: Major | Director/Board Member | |
Actus Administration A/S
Actus Administration A/S Miscellaneous Commercial ServicesCommercial Services Part of Actus AS, Actus Administration A/S is a Danish company that invites serious investors with a long-term strategy to invest in interesting property investment cases in growth areas throughout Denmark. The company is based in Aarhus, Denmark. As an investor in Actus, you become part of a community of interest with a common goal of an attractive return. Actus selects investment cases with a size that does not compete with the largest investors in the country but have potential. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
Ejendomsselskabet Hostruphus AS
Ejendomsselskabet Hostruphus AS Real Estate DevelopmentFinance Ejendomsselskabet Hostruphus AS provides housing rental services. The private company is based in Aarhus, Denmark. The Danish company was founded in 2018. Jesper Kaas Horsbøl has been the CEO of the company since 2018. | Real Estate Development | Chief Executive Officer Chairman | |
Ejendomsselskabet Skanderborgvej 156, Viby J. ApS | Chief Executive Officer | ||
Ejendomsselskabet Tværgade Silkeborg A/S
Ejendomsselskabet Tværgade Silkeborg A/S Real Estate DevelopmentFinance Part of Ejendomsselskabet Ravnsbjerggårdvej ApS, Ejendomsselskabet Tværgade Silkeborg A/S is a commercial real estate rental company based in Aarhus, Denmark. Ejendomsselskabet Tværgade Silkeborg A/S provides commercial real estate rental services. The Danish company was founded in 2018. The CEO is Jesper Kaas Horsbøl. | Real Estate Development | Chief Executive Officer Chairman | |
Ejendomsselskabet Stjernepladsen A/S
Ejendomsselskabet Stjernepladsen A/S Real Estate DevelopmentFinance Ejendomsselskabet Stjernepladsen A/S provides housing and commercial real estate services. The private company is based in Aarhus, Denmark. The CEO of the Danish company is Jesper Kaas Horsbøl. | Real Estate Development | Chief Executive Officer Chairman Director/Board Member | |
Ejendomsselskabet Engskovvænget A/S
Ejendomsselskabet Engskovvænget A/S Real Estate DevelopmentFinance Part of Ejendomsselskabet Engskovvænget Holding A/S, Ejendomsselskabet Engskovvænget A/S provides real estate rental services. The company is based in Aarhus, Denmark. The Danish company was founded in 2018. The CEO is Jesper Kaas Horsbøl. | Real Estate Development | Chief Executive Officer Chairman | |
Ejendomsselskabet Nørrebrogade 249 Holding II A/S
Ejendomsselskabet Nørrebrogade 249 Holding II A/S Financial ConglomeratesFinance Ejendomsselskabet Nørrebrogade 249 Holding II A/S is a non-financial holding private company based in Aarhus, Denmark. Ejendomsselskabet Nørrebrogade 249 Holding II A/S operates as a Danish non-financial holding company. The company was founded in 2016 and Jesper Kaas Horsbøl has been the CEO of the company since 2016. | Financial Conglomerates | Chief Executive Officer Director/Board Member | |
Ejendomsselskabet Nørrebrogade 249 AS
Ejendomsselskabet Nørrebrogade 249 AS Real Estate DevelopmentFinance Ejendomsselskabet Nørrebrogade 249 AS is a private company based in Aarhus, Denmark. Ejendomsselskabet Nørrebrogade 249 AS engages in rental of housing properties. The Danish company was founded in 2008. Jesper Kaas Horsbøl has been the CEO of the company since 2017. | Real Estate Development | Chief Executive Officer Chairman | |
Ejendomsselskabet Herluf Trolles Torv A/S
Ejendomsselskabet Herluf Trolles Torv A/S Real Estate DevelopmentFinance Part of Estatus Holding A/S, Ejendomsselskabet Herluf Trolles Torv A/S is a Danish real estate company founded in 2020. The company is based in Aarhus, Denmark and provides real estate services. | Real Estate Development | Chairman | |
Ejendomsselskabet Kongefolden 10-12 ApS
Ejendomsselskabet Kongefolden 10-12 ApS Real Estate DevelopmentFinance Ejendomsselskabet Kongefolden 10-12 ApS is a Danish company that rents houses. The private company is based in Aarhus, Denmark and was founded in 2016. | Real Estate Development | Director/Board Member Chairman | |
Ejendomsselskabet Hillerød A/S
Ejendomsselskabet Hillerød A/S Real Estate DevelopmentFinance Founded in 2010, Ejendomsselskabet Hillerød A/S is a Danish company that rents commercial real estate property. Part of Ejendomsselskabet Hillerød Holding A/S, the company is based in Aarhus, Denmark. | Real Estate Development | Director/Board Member Director/Board Member | |
Ejendomsselskabet Mathilde Parken AS | Chief Executive Officer Director/Board Member | ||
Ejendomsselskabet Ribersgade AS | Director/Board Member | ||
Affinicon ApS
Affinicon ApS Pharmaceuticals: MajorHealth Technology Affinicon ApS operates as a biotechnology company. It develops combinatory drugs for treatment of diseases such as inflammation, infections, and certain forms of cancer. The firm exploits a novel platform technology for targeted delivery of known drugs to macrophages. The company was founded by Niels Jonas Heilskov Graversen on July 4, 2013 and is headquartered in Aarhus, Denmark. | Pharmaceuticals: Major | Chairman | |
Advanced MR Analytics AB
Advanced MR Analytics AB Medical SpecialtiesHealth Technology Advanced MR Analytics AB offers solutions for body composition analysis. It transforms subjective magnetic resonance images into fat and muscle measurements. The firm provides technical research such as data acquisition and reconstruction; registration and fusion; machine learning and signal representation; modelling and simulation; simulation, classification, and quantification; visualization and image enhancement; and user interfaces and interaction. The company was founded by David Magnus Borga and Olof Erik Gunnar Dahlqvist Leinhard in 2010 and is headquartered in Link?ping, Sweden. | Medical Specialties | Director/Board Member |
Statistiche
Distribuzione geografica
Danimarca | 27 |
Svezia | 4 |
Canada | 2 |
Finlandia | 2 |
Paesi Bassi | 2 |
Settori
Finance | 12 |
Health Technology | 11 |
Commercial Services | 5 |
Consumer Services | 3 |
Process Industries | 2 |
Posizioni
Director/Board Member | 27 |
Chairman | 9 |
Chief Executive Officer | 8 |
Corporate Officer/Principal | 3 |
Independent Dir/Board Member | 1 |
Contatti più connessi
Insiders | |
---|---|
Søren Møller | 21 |
Claus Møller | 14 |
Jesper Kaas Horsbøl | 11 |
Stone Danvig Lildal | 2 |
- Borsa valori
- Insiders
- Peter Grydholdt Sørensen
- Connessioni Società